SEC 13F Intelligence

Blair William & Co/Il / DC4

Blair William & Co/Il’s Dexcom Inc Position

Does Blair William & Co/Il own Dexcom Inc (DC4)? Yes — 1.93M shares worth $121M (+0.35% of its 13F portfolio) as of Q1 2026, down from 1.99M shares the prior filed quarter.

Position Value
$121M
Q1 2026
Shares
1.93M
% of Portfolio
+0.35%
Quarters Held
30
currently held

Position History DC4

Reported value by quarter
Q4 ’18: $116MQ4 ’18Q1 ’19: $120MQ2 ’19: $171MQ3 ’19: $171MQ4 ’19: $264MQ4 ’19Q1 ’20: $306MQ2 ’20: $435MQ3 ’20: $431MQ4 ’20: $400MQ4 ’20Q1 ’21: $426MQ2 ’21: $515MQ3 ’21: $658MQ4 ’21: $633MQ4 ’21Q1 ’22: $594MQ2 ’22: $336MQ3 ’22: $372MQ4 ’22: $501MQ4 ’22Q1 ’23: $506MQ2 ’23: $570MQ3 ’23: $421MQ4 ’23: $554MQ4 ’23Q1 ’24: $629MQ2 ’24: $487MQ3 ’24: $184MQ4 ’24: $174MQ4 ’24Q1 ’25: $153MQ2 ’25: $193MQ3 ’25: $142MQ4 ’25: $132MQ4 ’25Q1 ’26: $121Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.93M$121M+0.35%
Q4 20251.99M$132M+0.35%
Q3 20252.11M$142M+0.38%
Q2 20252.21M$193M+0.54%
Q1 20252.24M$153M+0.46%
Q4 20242.23M$174M+0.51%
Q3 20242.74M$184M+0.54%
Q2 20244.30M$487M+1.50%
Q1 20244.53M$629M+1.97%
Q4 20234.47M$554M+1.89%
Q3 20234.51M$421M+1.61%
Q2 20234.43M$570M+2.09%
Q1 20234.36M$506M+2.02%
Q4 20224.42M$501M+2.18%
Q3 20224.62M$372M+1.71%
Q2 20224.50M$336M+1.49%
Q1 20221.16M$594M+2.08%
Q4 20211.18M$633M+1.99%
Q3 20211.20M$658M+2.24%
Q2 20211.21M$515M+1.79%
Q1 20211.19M$426M+1.61%
Q4 20201.08M$400M+1.47%
Q3 20201.05M$431M+1.83%
Q2 20201.07M$435M+2.08%
Q1 20201.14M$306M+1.91%
Q4 20191.21M$264M+1.35%
Q3 20191.15M$171M+0.99%
Q2 20191.14M$171M+0.97%
Q1 20191.01M$120M+0.73%
Q4 2018965.6K$116M+0.84%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Blair William & Co/Il’s full portfolio or all institutional holders of DC4.